Drug Database
Back to search

Norway· NO-ID_18AA14DF-19BE-4A29-9CEB-5462FD279913

Spravato

A esketamine product containing esketamine, registered in Norway by Janssen-Cilag International N.V.. The same ATC class is registered in 11 of our 19 countries.

ATC N06AX27

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedSpravatoATCN06AX27REGISTER NO.NO-ID_18AA14DF-19BE-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about esketamineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Esketamine is registered in 11 of 19 countries.

Countries holding a registration under ATC N06AX27 (esketamine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose
Search esketamine products by name

Esketamine · ATC N06AX27

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of esketamine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Esketamine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$66.47
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Esketamine
Manufacturer
Janssen-Cilag International N.V.
Country
Norway (NO)
ATC code
N06AX27
ATC class
Esketamine
Defined daily dose
8 mg, N
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_18AA14DF-19BE-4A29-9CEB-5462FD279913
  • no_varenummer
    432424
    0.2
    NOK 2643.7
  • gtin
    7323281005216

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

91 interactions on record for esketamine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check esketamine against other medicinesHow interaction checks work

Esketamine · interactions on record

91 records

  • 7 severe
  • 84 moderate

Most severe, free to view

  • PhentermineA08AA01severe
  • FenfluramineA08AA02severe
  • MazindolA08AA05severe
  • FenfluramineN03AX26severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Esketamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All esketamine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Escetex, Eskelan
  • Belgium · Esketamine Kalceks, Vesierra
  • Germany · Esketamin, Esketamin Inresa
  • Denmark · Esketamine Orifarm, S-Ketamin Pfizer
  • Estonia · Esketex
  • Finland · Esketamine Kalceks, Esketamine Orifarm
  • France · Eskesia, Esketamine Renaudin
  • United Kingdom (Northern Ireland) · Esketamine Idd, Esketamine Kalceks
  • Croatia · Esgamda
  • Iceland · S-Ketamin Pfizer, Spravato
  • Liechtenstein · Spravato
  • Luxembourg · Vesierra
  • Latvia · Esketamine Kalceks
  • Netherlands · Esketamine Focus, Esketamine Idd
  • Sweden · Esketamine Kalceks, Esketamine Orifarm
  • Slovenia · Esketamin Kalceks, Sinmelan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8b1417cb-a649-4426-bb13-e4db8dc4a152
GET /v1/drugs/8b1417cb-a649-4426-bb13-e4db8dc4a152?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nesespray, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Esketamin",
  "merkevare_id": "ID_18AA14DF-19BE-4A29-9CEB-5462FD279913",
  "name_form_strength": "Spravato nesespray oppl 28 mg",
  "prescription_group": "A"
}
API referenceMCP serverPlans

See everything about esketamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console